Earlier this week, contract development and manufacturing organization (CDMO) Shilpa announced it will invest $50 million to ...

The BioVentureHub is one of the country’s many platforms that open lines of communication between companies to share ideas ...

Explore how process intensification is fundamentally transforming bioprocessing and defining the future of next-gen ...

Ab platforms built the industry, but complex formats like ADCs, bsAbs, and Fc fusions demand new CMC and facility strategies.

Verigraft is developing decellularized vein grafts to treat chronic venous insufficiency without immunosuppression, with trials underway.

On 27 October 2026, B2B pharma company Adalvo announced its acquisition of a romiplostim biosimilar program from India-based ...

Incremental, vertical implementation of data systems and process analytics will help biomanufacturers work toward autonomous ...

The close to $300 million expansion will include a manufacturing facility and a carbon net-zero emissions warehouse in Lessines, Belgium, says Takeda. The firm announced its biggest investment to date ...

Ionizing-technology–based industries are growing rapidly around the world. The expansion is driven mostly by the technology’s myriad applications, including polymer crosslinking, medical device ...

The biopharmaceutical industry continues to grow globally as it recovers from the COVID-19 pandemic. The significant COVID-driven expansion of bioprocessing activities worldwide created supply-chain ...

Figure 1A: Antibody–drug conjugate (ADC) structure and delivery pathways; linker chemistry determines the mechanism by which cytotoxin release occurs. This schematic shows a monoclonal antibody (MAb) ...